Cargando…
Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China
Background: Antidepressant (AD) algorithm is an important tool to support treatment decision-making and improve management of major depressive disorder (MDD). However, little is known about its concordance with real-world practice. This study aimed to assess the concordance between the longitudinal...
Autores principales: | Yang, Lu, Su, Yousong, Dong, Sijia, Wu, Tao, Zhang, Yongjing, Qiu, Hong, Gu, Wenjie, Xu, Yifeng, Wang, JianLi, Chen, Jun, Fang, Yiru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471191/ https://www.ncbi.nlm.nih.gov/pubmed/36120331 http://dx.doi.org/10.3389/fphar.2022.954973 |
Ejemplares similares
-
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
por: Yatham, Lakshmi N, et al.
Publicado: (2018) -
Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
por: Zhu, Yuncheng, et al.
Publicado: (2023) -
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial
por: Yatham, L N, et al.
Publicado: (2016) -
Investigation of the pharmacological treatment patterns of Chinese patients with major depressive disorder under real-world settings using multi-channel sequence analysis
por: Wu, Tao, et al.
Publicado: (2023) -
Does the Ranking Matter? A Retrospective Cohort Study Investigating the Impact of the 2018 CANMAT and ISBD Guidelines for the Management of Patients with Bipolar Disorder Treatment Recommendations for Acute Mania on Rehospitalization Rates
por: Gomes, Fabiano A., et al.
Publicado: (2023)